These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3145357)

  • 41. [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS].
    Fröhlich B; Ahrens S; Burdach S; Klingebiel T; Ladenstein R; Paulussen M; Zoubek A; Jürgens H
    Klin Padiatr; 1999; 211(4):284-90. PubMed ID: 10472563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
    Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Alternative chemotherapy of malignant bone neoplasms in children].
    Jurczyk-Procyk S; Perek D
    Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of soft tissue sarcomas in childhood and adolescence: results of the CWS-81 multicenter therapy study].
    Koscielniak E; Treuner J; Jürgens H; Winkler K; Bürger D; Herbst M; Ritter J; Niethammer D; Müller-Weihrich S; Bernhard G
    Klin Padiatr; 1991; 203(4):211-9. PubMed ID: 1942928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapy of Ewing's sarcoma].
    Dunst J; Sauer R
    Strahlenther Onkol; 1993 Dec; 169(12):695-708. PubMed ID: 8284742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results].
    Paulussen M; Ahrens S; Braun-Munzinger G; Craft AW; Dockhorn-Dworniczak B; Dörffel W; Dunst J; Fröhlich B; Göbel U; Häussler M; Klingebiel T; Koscielniak E; Mittler U; Rübe C; Winkelmann W; Voûte PA; Zoubek A; Jürgens H
    Klin Padiatr; 1999; 211(4):276-83. PubMed ID: 10472562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
    Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
    J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
    Lee JA; Kim DH; Cho J; Lim JS; Koh JS; Yoo JY; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
    Jpn J Clin Oncol; 2011 Jun; 41(6):776-82. PubMed ID: 21415003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The CESS 81 cooperative Ewing sarcoma study of the Society for Pediatric Oncology: an interim report].
    Jürgens H; Cserhati M; Göbel U; Gutjahr P; Jobke A; Kaatsch P; Kühl J; Sekera J; Winkler K
    Klin Padiatr; 1983; 195(3):207-13. PubMed ID: 6192282
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
    Ahrens S; Hoffmann C; Jabar S; Braun-Munzinger G; Paulussen M; Dunst J; Rübe C; Winkelmann W; Heinecke A; Göbel U; Winkler K; Harms D; Treuner J; Jürgens H
    Med Pediatr Oncol; 1999 Mar; 32(3):186-95. PubMed ID: 10064186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases.
    Burdach S; Thiel U; Schöniger M; Haase R; Wawer A; Nathrath M; Kabisch H; Urban C; Laws HJ; Dirksen U; Steinborn M; Dunst J; Jürgens H;
    Bone Marrow Transplant; 2010 Mar; 45(3):483-9. PubMed ID: 19684633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Results of the treatment of non-rhabdomyosarcomatous soft tissue neoplasms within the scope of the CWS 81 study].
    Treuner J; Suder J; Gerein V; Beck J; Winkler K; Weinel F; Gnekow A; Niethammer D
    Klin Padiatr; 1987; 199(3):209-17. PubMed ID: 3626423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
    Schuck A; Hofmann J; Rübe C; Hillmann A; Ahrens S; Paulussen M; Jürgens H; Dunst J; Willich N
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1001-6. PubMed ID: 9869222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cooperative therapy study of nontesticular germ cell tumors MAKEI 83 of the Society of Pediatric Oncology: analysis after 3 years].
    Göbel U; Gutjahr P; Jürgens H; Kabisch H; Lampert F; Spaar HJ; Sternschulte W; Harms D
    Klin Padiatr; 1986; 198(3):237-44. PubMed ID: 2425122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Results of treatment of rhabdomyosarcomas (RMS) in children. A report of the Cooperative Soft Tissue Sarcoma Study (CWS-81) of the Society of Pediatric Oncology].
    Treuner J; Kaatsch P; Anger Y; Seipp A; Spaar HJ; Gerein V; Suder J; Niethammer D
    Klin Padiatr; 1986; 198(3):208-17. PubMed ID: 3523026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81.
    Sauer R; Jürgens H; Burgers JM; Dunst J; Hawlicek R; Michaelis J
    Radiother Oncol; 1987 Oct; 10(2):101-10. PubMed ID: 3423301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
    Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
    Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
    Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R
    J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
    Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ;
    Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.